Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis (2014)
- Authors:
- USP affiliated authors: MACHADO, UBIRATAN FABRES - ICB ; GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM
- Unidades: ICB; FM
- DOI: 10.1517/14728214.2014.875530
- Subjects: FISIOLOGIA; GLICOSE; DIABETES MELLITUS; HEMOGLOBINAS; MEDICAMENTO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Expert Opinion on Emerging Drugs
- ISSN: 1744-7623
- Volume/Número/Paginação/Ano: v. 19, n. 1, p. 5-9, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
MACHADO, Ubiratan Fabres e GIANNELLA, Maria Lúcia Cardillo Côrrea. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis. Expert Opinion on Emerging Drugs, v. 19, n. 1, p. 5-9, 2014Tradução . . Disponível em: https://doi.org/10.1517/14728214.2014.875530. Acesso em: 13 fev. 2026. -
APA
Machado, U. F., & Giannella, M. L. C. C. (2014). Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis. Expert Opinion on Emerging Drugs, 19( 1), 5-9. doi:10.1517/14728214.2014.875530 -
NLM
Machado UF, Giannella MLCC. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis [Internet]. Expert Opinion on Emerging Drugs. 2014 ; 19( 1): 5-9.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1517/14728214.2014.875530 -
Vancouver
Machado UF, Giannella MLCC. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis [Internet]. Expert Opinion on Emerging Drugs. 2014 ; 19( 1): 5-9.[citado 2026 fev. 13 ] Available from: https://doi.org/10.1517/14728214.2014.875530 - SLC2A4gene: a promising target for pharmacogenomics of insulin resistance [Editorial]
- Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells
- Expression analysis of proto-oncogene ret in patients with primary hyperparathyroidism: comparison between hyperplasia, adenoma and carcinoma
- Continuous glucose monitoring system: dawn period calibration does not change accuracy
- Sex-specific associations of variants in regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes with kidney disease in type 1 diabetes
- Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta]
- Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice
- Association between tumor GHSR-IA mRNA expression and in vivo response to GHRP-6 in patients with ACTH-dependent Cushing`s syndrome
- Visceral adiposity syndrome
- Polymorphisms in the gene encoding glucose transporter Glut-1 (SLC2A1) and renal disease in type 1 diabetic patients
Informações sobre o DOI: 10.1517/14728214.2014.875530 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
